You can either interpret as FDA trying to ensure it clears all potential future hurdles by being so thorough upfront or you can interpret it as them being inconsistent in what hurdles they set. Personally I think we need to think about bringing in different consultants as they appear dead set on putting the starting high jump hurdle at 2:65m
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.010(2.44%) |
Mkt cap ! $166.9M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 42.0¢ | 40.0¢ | $168.2K | 411.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 50665 | 2 |
View Market Depth
| Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |